Allergen immunotherapy for prevention and treatment of respiratory allergy in childhood;Inmunoterapia con alergenos para la prevención y el tratamiento de las enfermedades alérgicas respiratorias de la infancia

Archivos Argentinos de Pediatria

Volumn 108, Issue 3, 2010, Pages 258-265

  Saranz, Ricardo J ^a   Lozano, Alejandro ^a   Cáceres, María E ^a   Arnolt, Roque G ^a   Máspero, Jorge F ^a   Bozzola, César M ^a   Neffen, Hugo E ^a   Croce, Víctor H ^a   Gualtieri, Octavio ^a   Procopio, Norberto ^a   Skrie, Víctor ^a   Bandin, Gloria ^a   Claeys, Renée ^a   Mindel, Elsa B ^a   Miño, Ofelia ^a   García, Jorge ^a   Segovia, Antonio Sánchez ^a   Mariño, Andrea ^a   Cavallo, Aldo ^a   Bustos, Guillermo J ^a   Orellana, Julio ^a   Blanco, Adolfo ^a   Quinteros, Cristina ^a   Sala, Andrea ^a   Sasia, Laura ^a   Sancho, Marta ^a   Salvucci, Karina ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 18;

ARTICLE; CONJUNCTIVITIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; RESPIRATORY TRACT ALLERGY; TH1 CELL; TH2 CELL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

CHILD; DESENSITIZATION, IMMUNOLOGIC; HUMANS; RESPIRATORY HYPERSENSITIVITY;

EID: 77953646522     PISSN: 03250075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Schoenwetter WF, Dupclay L Jr, Appajosyula S, Botteman MF, et al. Economic impact and quality of life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305-317. (Pubitemid 38344119)
2. Kocabas CN, Civelek E, Sackesen C, Orphan F, et al. Burden of rhinitis in children with asthma. Pediatr Pulmonol 2005;40:235-240.
3. Bousquet J, Khaltaev N, Cruz AA, Denburg J, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008;63 (suppl. 86):8-160.
4. Passalacqua G, Durham SR. Allergic rhinitis and its impacts on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007;119:881-991. (Pubitemid 46527840)
5. Bousquet J, Lockey R, Malling H. WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53 (suppl. 54):1-15.
6. American Academy of Allergy Asthma and Immunology/American College of Allergy Asthma and Immunology Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol 2003;90 (suppl.1):1-40.
7. Cox L, Li JT, Nelson H, Lockey R. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120: s25-s85. (Pubitemid 47313519)
8. Noon L. Prophylactic inoculation against hay fever. Lancet 1911;(1):1572-1573.
9. Norman PS. Immunotherapy: past and present. J Allergy Clin Immunol 1998;102:1-10.
10. Norman PS. Immunotherapy 1999-2004. J Allergy Clin Immunol 2004;113:1013-1023.
11. Roder E, Berger MY, de Groot H, van Wijk RG. Immunotherapy in children and adolescent with rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol 2008;19:197-207. (Pubitemid 351499173)
12. Compalati E, Panagos M, Tarantini F, Pasalacqua G, et al. Specific immunotherapy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol 2009;102:22-28.
13. Larenas-Linnemann D. Sublingual immunotherapy in children: complete and update review supporting evidence of effect. Curr Opin Allergy Clin Immunol 2009;9:168-176.
14. Frew AJ. Sublingual immunotherapy. N Engl J Med 2008;358:2259-64.
15. Passalacqua G, Pawankar R, Baena-Cagnani CE, Canonica GW. Sublingual immunotherapy: where do we stand? Present and future. Curr Opin Allergy Clin Immunol 2009;9:1-3.
16. Bozzola CM. Principios de la tolerancia oral. Arch Alergia Immunol Clin 2003;34(1):2-5.
17. Pipet A, Botturi K, Pinot D, Vervloet D, et al. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med 2009;103:800-812.
18. Moingeon P, Batard T, Fadel R, Frati F, et al. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006;61:151-165. (Pubitemid 43381824)
19. Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma 2009;46:322-334.
20. Novak N. Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol 2007;7:542-546. (Pubitemid 350076451)
21. Halken S, Lau S, Valovirta E. New visions in specific immunotherapy in children: an iPAC summary and future trends. Pediatr Allergy Immunol 2008;19(suppl. 19):60-70.
22. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003;(4):CD001186.
23. Calamita S, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the Cochrane collaboration method. Allergy 2006;61:1162-1172.
24. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, et al. Meta-analysis of the efficacy of sublingual immunotherapy in allergic asthma in pediatric patient 3 to 18 years of age. Chest 2008;133: 599-609. (Pubitemid 351367366)
25. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and metaanalysis. Allergy 2005:60:4-12.
26. Penagos M, Compalati E, Tarantini F, Baena-Cagnani CE, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:(2)141-148. (Pubitemid 44272577)
27. Des Roches A, Paradis L, Menardo JL, Bouges S, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract.VI: Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997;99:450-453. (Pubitemid 27173080)
28. Inal A, Altunas DU, Yilmaz M, Karacok GB, et al. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol 2007;17:85-91. (Pubitemid 46623709)
29. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, et al and the PAT investigator group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-948.
30. Marogna M, Tomassetti D, Bernasconi A, Colombo F, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008;101:206-211.
31. Shapiro GG. Among young children who wheeze, which children will have persistent asthma? J Allergy Clin Immunol 2006;118:562-564.
32. Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol 2009;123:763-769.
33. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34.
34. Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: result of a GA2LEN meta-analysis. Allergy 2009;64:1570-1579.
35. Weber RW. Guidelines for using pollen cross-reactivity in formulating allergen immunotherapy. J Allergy Clin Immunol 2008;122:219-221.
36. Esch RE. Allergen immunotherapy: what can and cannot be mixed? J Allergy Clin Immunol 2008;122:659-660.
37. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;82:797-802.
38. Di Rienzo VD, Minelli M, Musarra A, Sambugaro R, et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005;35:560-564.
39. van Wijk RG. When to initiate immunotherapy in children with allergic disease? Lessons from the paediatric studies. Curr Opin Allergy Clin Immunol 2008;8:565-570.
40. Campbell DM. Sublingual immunotherapy for children: are we there yet? Defining its role in clinical practice. Paed Respir Rev 2009;10:69-74.
41. Jacobsen L. Preventive aspects of immunotherapy: prevention for children at risk of developing asthma. Ann Allergy Asthma Immunol 2001;87(suppl 1):s43-s46. (Pubitemid 32661329)
42. Antúnez C, Mayorga C, Corzo JL, Jurado A, et al. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration. Pediatr Allergy Immunol 2008;19:210-218.
43. Windom HH, Lockey RF. An update on the safety of specific immunotherapy. Curr Opin Allergy Clin Immunol 2009;8:571-576.
44. Valovirta E, Jacobsen L, Ljorring C, Koivikko A, et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 2006;61:1177-1183.
45. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, et al. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62:317-324.
46. Brüggenjürgen B, Reinhold T, Brehler R, Laake E, et al. Cost-effectiveness of subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma. Ann Allergy Asthma Immunol 2008;101:316-324.
47. Ciprandi G, Agostinis F, Amoroso S, Ariano R, et al. Economic evaluation of sublingual immunotherapy: an analysis of literature. Eur Ann Allergy Clin Immunol 2007;39:21-26.
48. Thomas WR. Innovation in immunotherapy. Clin Exp Allergy 2009;39:450-454.
49. Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic diseases. Nature Rev (Drug Discovery) 2009;8:645-660.